chrisvoncsefalvay/vaers-outcomes huggingface dataset:
left injection site arm sore for 72 hours; left injection site arm swollen for 72 hours; left injection site arm red for 72 hours; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (left injection site arm sore for 72 hours), VACCINATION SITE SWELLING (left injection site arm swollen for 72 hours) and VACCINATION SITE ERYTHEMA (left injection site arm red for 72 hours) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE PAIN (left injection site arm sore for 72 hours), VACCINATION SITE SWELLING (left injection site arm swollen for 72 hours) and VACCINATION SITE ERYTHEMA (left injection site arm red for 72 hours). On 17-Apr-2021, VACCINATION SITE PAIN (left injection site arm sore for 72 hours), VACCINATION SITE SWELLING (left injection site arm swollen for 72 hours) and VACCINATION SITE ERYTHEMA (left injection site arm red for 72 hours) had resolved.            Concomitant medication was not provided.  Treatment information was not provided.
Shortly after the vaccine, I noticed a darkening in gums.  I went to the dentist and a dental oral surgeon to have lichen planus diagnosed in the gum area.  This was I also have a rash on my stomach that has not been diagnosed.
Red rash - pimples - itching - Burning - fever Around my neck both ears hot ears - still have rash and itching
Patient stated he had dose one 4-weeks prior, however he was only 3 weeks and as a result got the vaccine one week early.
Noticed a strong tingling senssation on entire left side of chest and left arm and pain on right side of neck. The sensallon was very similar to the sensation when your foot'  falls asleep' This lasted on and off for 2+ weeks. Ultimately, the sensations have mostly subsided but was immediately replaced with very strong heart beats and palpitations . The frequnecy and  intensity increased and I decided to consult wit my PCP,  on June 14, 2021. PCP performed standard in office consult and made stat referral to  Cardiologist.   Cardiologist ordered several tests and prescribed multile medications.
Two days prior to vaccination, I went to medical facility to have a Covid test.  They took my vitals (which we discussed because they were so good - nurse asking me about being a cyclist.). Vitals:  122/77, 46 heart rate.  Monday, August 9th - I got my first shot of Pfizer vaccine.  By that night and into the next 4 days, I am down with low energy, lethargic, just dark, depression, cloudy fog on the brain.  Some moments seemed to be better.    Saturday, August 14th, I woke up - as I had been doing all week - in the middle of the night at 3:30am to go pee.  I decided to get up and take my blood pressure, because my ears were ringing and I felt as if my "blood was boiling" (as if I had down 12 espresso shots).  Sure enough, my reading was 155/97.      I went to an urgent care yesterday to see what they could do.  They said they couldn't do anything and that I would need to either go to ER or see a cardiologist.  They could draw blood to see a panel but there was really nothing else they could do.  Today (Sunday August 15th) - nothing has changed.  Feeling "off balance", slightly dizzy, bad ringing in the ears and no energy, and blood pressure has kept up around the same level between 140/40 and 155/95.  The ear ringing has not stopped.  Not hungry. Feel really run down and not wanting to do anything.
Information has been received from a nurse via a company representative referring to patient of unknown age and gender. The patient's concurrent condition and medical history were not reported. On 31-MAR-2015 the patient was vaccinated with a dose of VARIVAX (Merck) (lot#, expiration date, dose and route were unknown) instead of ZOSTAVAX. No adverse effects were reported. Additional information has been requested.
Information has been received from a Physician (MD) concerning a patient of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. Concomitant therapies were not provided. On an unknown date, the patient was vaccinated with an unspecified dose of PEDVAXHIB (lot number J016188 with an unspecified expiration date in October 2016) (strength, dosage schedule, route of administration and anatomical location were not provided), which was involved in a temperature excursion. It was unknown whether laboratory diagnostics studies were performed. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
Woke up on 04/10/21 with intense body pain, dizziness, weakness and since.
out of 35 vaccines this is 1 of 3 pt from this site to exp lightheadedness, dizziness & weakness w/in min of vax;pt was eval in ER;
Drug ineffective; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Nov2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (unspecified if ongoing); "Hypercalcemia" (unspecified if ongoing). There were no concomitant medications. Patient had no known allergies.  The following information was reported: COVID-19 (medically significant) with onset 2023, outcome "unknown", described as "COVID 19 Treatment"; DRUG INEFFECTIVE (medically significant) with onset 2023, outcome "unknown". Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 10Feb2023 to 13Feb2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
I have had a weekly routine of fasting one day a week for the last 20 years. Sometimes I would extend this to 3 days, water only. I am healthy, 6'1" weight 170-180 all of my adult life. Resting HR <56. 9 days after having my first vaccination, I did a 24 hour fast. I woke at 2 am to go to the bathroom. I became lightheaded and passed out while standing over the toilet. I layed on the floor for over 5 minutes with my head spinning. I then realized I was hypoglycemic. I have never had this issue. I took some orange juice and recovered my strength. I hit my head on the top of the toilet which required my to have 5 sutures in my chin at the ER that night.  Today I was working out for 30 minutes on an elliptical. I work out 4 to 5 times weekly.  10 minutes after returning to my room I noticed I was dizzy and checked my pulse from my watch. My HR was 210. this lasted for over 10 minutes. I have never had this issue.   I believe it would not be in my best interest to take the second vaccination.
Dark red circular bruise; Swollen upper arm; Bruise became hard like rock the size of a silver dollar; In the center was a red dot where the patient got injected; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Dark red circular bruise), PERIPHERAL SWELLING (Swollen upper arm), VACCINATION SITE INDURATION (Bruise became hard like rock the size of a silver dollar) and VACCINATION SITE ERYTHEMA (In the center was a red dot where the patient got injected) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (Dark red circular bruise), PERIPHERAL SWELLING (Swollen upper arm), VACCINATION SITE INDURATION (Bruise became hard like rock the size of a silver dollar) and VACCINATION SITE ERYTHEMA (In the center was a red dot where the patient got injected). At the time of the report, VACCINATION SITE BRUISING (Dark red circular bruise), PERIPHERAL SWELLING (Swollen upper arm), VACCINATION SITE INDURATION (Bruise became hard like rock the size of a silver dollar) and VACCINATION SITE ERYTHEMA (In the center was a red dot where the patient got injected) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Patient began rubbing and putting pressure on vaccination site believing that may help to resolve the issue.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up document included reporter contact details was updated.
urinary tract infection; barely hit her arm against the counter, and her right deltoid was red, warm, and felt kind of sore"; barely hit her arm against the counter, and her right deltoid was red, warm, and felt kind of sore"; barely hit her arm against the counter, and her right deltoid was red, warm, and felt kind of sore"; barely hit her arm against the counter, and her right deltoid was red, warm, and felt kind of sore"; This spontaneous report was received from a nurse concerning to a 67 year old female patient. The patient's current conditions included hypertension, hypercholesterolaemia, diverticulitis, gastric ulcer, vitamin d deficiency, gastrooesophageal reflux disease. The patient's concomitant therapies included omeprazole (PRILOSEC), pravastatin, meloxicam (MOBIC), glucosamine, valsartan (DIOVAN) and vitamin d (unspecified). The patient' s drugs allergies included penicillin (unspecified), quinapril hydrochloride (ACCUPRIL) and sulfacetamide sodium (+) sulfadiazine (+) sulfamethazine (SULFA).  On 11-JUN-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 0.5 ml, once dose, by intramuscular route (lot # R024025 and expiration date 02-SEP-2020) for pneumococcal prevention. On 12-JUN-2019, the patient developed a urinary tract infection on the night (clarified as burning and pressure). On 13-JUN-2019, the patient arrived back to clinic for medical attencion. While at the clinic, the patient ''barely hit her arm against the counter (limb injury), and her right deltoid was red, warm, and felt kind of sore''. She patient had performed a culture/sensitive and complete urinalysis (U/A) (results were pending). The patient was thus prescribed cephalexin (KEFLEX) 500 mg capsules by mouth three times daily.   The outcome of urinary tract infection, erythema, pain in extremity, feeling hot and limb injury was reported as not recovered.    The causal relationship between the events with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)  was not provided.
her blood pressure has been slowly going up; This is a spontaneous report from a contactable consumer (patient). A 90-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 10Feb2021 (at the age of 90-years-old) (Batch/Lot Number: EL9263; Expiration Date: 31May2021) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included macular degeneration from 2005 and ongoing. The patient's concomitant medications were not reported. Patient previously took first dose of bnt162b2 (Batch/Lot Number: EL3248; Expiration Date: 30Apr2021) administered in left arm on 20Jan2021 for covid-19 immunisation. The caller reported that her blood pressure had been slowly going up a little bit on 14Feb2021. It was reported that her blood pressure was 141/85 yesterday on 14Feb2021. On 15Feb2021 in morning, her blood pressure was fluctuating and it was 179/105. Patient did not receive additional vaccines on same date of the Pfizer suspect. Prior Vaccinations (within 4 weeks) was reported as Covid-19 vaccine. Outcome of the event was not recovered.   Follow-up attempts are completed. No further information is expected.
Initial unsolicited report received from other non-healthcare professional on 04 October 2016. This case involves four patients (age and gender not reported) who were vaccinated with dose of Fluzone QIV (Batch number: UI625AB, expiration date 30 June 2017, site and route of administration was not reported) on 13 September 2016. Patient's Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions: none reported. Concomitant medication was not reported as denies. On 13 September 2016, same day following vaccination patients experienced muscle soreness to arm that was still bothersome, waking them up at night and some patient unable to lift arm over head. Lab data and corrective treatment were not reported. Outcome of events reported as unknown. List of documents held by sender: none.
Swollen lymph node in Left Armpit; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 06Apr2021 at 11:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have allergies to medications, food, or other products. Concomitant medications include MULTI-VITAMINS, vitamin c (MANUFACTURER UNKNOWN) , vitamin d nos (VITAMIN D), zinc (MANUFACTURER UNKNOWN) and quercetin (MANUFACTURER UNKNOWN) all taken for unknown indication, from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 the patient experienced swollen lymph node in his left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse event. The clinical outcome of the event swollen lymph node in left armpit was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
In reviewing client's records for further immunizations, it was noted that the client's second Hep A was given too soon.  He experienced no adverse events to the vaccine.  I spoke with client's guardian to explain the situation and recommended that he be revaccinated.  Client's guardian agreed and scheduled appointment for Hep A vaccine.
Pain, swelling redness, hot to the touch the first day. Second day - same only the swelling and redness increased to a size of about 4" in diameter swelling site was very hard to the touch. Site was very hot and painful and hard to the touch. Third day - same but the size increased to close to 5" in diameter and began to itch. Fourth day - swelling decreased somewhat but was still hot to the touch. Redness began to turn a purple color. Fifth and following days - redness decreased, but the discoloration remained. Still warm to the touch. Skin is blotchy and has tiny raised bumps like "orange skin." Increased itching. Mild swelling persists. Today is the tenth day after the injection, and there is still itching (sometimes severe), mild swelling of a diameter of about 3-3.5", blotchiness, discoloration, bumpy skin and warmth at the injection site.
This spontaneous report as received from a pharmacist refers to a 54 year old male patient with an unspecified pulmonary disorder and drug reaction/allergies to tramadol.  On 21-JUL-2014 the patient was vaccinated with ZOSTAVAX, lot #J014812, expiration date 20-FEB-2015, subcutaneous in the left arm. Dose ws not reported. Concomitant  therapies included oxygen. On 21-JUL-2014, the patient experienced redness, swelling and irritation at the injection site. The area of reaction extended toward the left elbow. The outcome of redness, swelling and irritation at the injection site was reported as recovered (on 28-JUL-2014). No treatment was given for adverse events. No lab diagnostics studies were performed. The patient sought medical attention. Additional information has been requested.
Next morning after flu shot awoke with reddened @ elbow, "heavy" sensation in L arm, increased intensity and extending to L shoulder shoulder posteriorly 2 days after shot. Mild stomach pain and diarrhea 2 days after.
Initial misuse report received from a health care professional on 25 February 2014. The cases were received at GPV on 21 March 2014.   A patient (no information was provided regarding the patient) had received dose of FLUZONE, ACTHIB; DAPTACEL; PENTACEL; MENACTRA, ADACEL 30 F multiple times daily for 20 minutes each time since 2/7 on an unspecified date, i.e. incorrect product storage. No adverse event was reported. List of documents held by sender: none
Initial information has been received from an other health professional refers to a 20 years old male patient with hemiplegic cerebral palsy, seizure disorder and botulinum toxin pertussis allergy, who on 31-AUG-2006, the patient was vaccinated with a dose of (Merck) VARIVAX (dose, route, indication and lot number were not reported). On 13-AUG-2009, the patient received a dose of (Merck) VARIVAX (dose, route, indication and lot number were not reported). No other co-suspects were reported. Concomitant medications included: clindamycin. In November 2012, the patient experienced chickenpox and other systemic symptoms as: itching, an malaise. The patient had a maximum temperature of 40 degrees C. The patient had a hundred of lesions in the face, chest, back and abdomen. The patient had not a recent exposure to chickenpox. The vaccine did not developed rash. On 19-NOV-2012, VZVIP specimen was obtained from vesicle or lesion from skin. No treatment information was reported. At the time of report, the patient recovered from the events (approximately in 2012). Additional information is not expected.
I first had several red bumps on the backs of my legs that looked like mosquito bites. Over the next couple of days, they kept multiplying and became swollen and  itchy. Some of them felt warm to the touch. Thanks I now have them on my arms, elbows, front and back of legs, neck, right buttock ankles and left foot.
Severe pain and numbness in the arm. Severe headache leg and body ache. Malaise, weakness and difficulty walking.
Client had one Hep-B 8 yrs ago and had migraines for 1 wk. In April 20, 2006, she thought enough time had lapsed and she'd try again. Once again, migraines occurred in 12 hrs post Heb-B #2. She does not need for her job. I told her to check with her physician as to whether she should risk #3 Hep-B. She also now admits whenever she eats yeast products, migraines occur. She felt it couldn't happen with vaccine. So she tried.
has numbness in both hands, but mainly her right hand, after the second vaccine; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received second dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number, Expiration date and NDC number was not reported), via an unspecified route of administration on 14Jun2021 as a single dose (at the age of 49-years-old) for covid-19 immunisation at hospital. The patient medical history and concomitant medications were not reported. Patient received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunisation. On Jun2021, patient had numbness in both hands, but mainly her right hand, after the second vaccine. Patient stated that for a half hour to 45 minutes, she had numbness in her right hand and stated that hand feels like if you hold a body part in the same position, for a long time, and it feels numb. Patient clarified that she feels the numbness in both of her hands, mainly her right hand. Patient asked if it was normal to have this effect or she should worry and asked if this effect was alright to had, or should she go to a doctor. The outcome of the event was unknown.  Information on batch/Lot number was not received. Further information has been requested.
Information has been received from a registered nurse concerning a 30 year old male with no known drug allergies who on 05/02/2001 was vaccinated with a first dose of varicella vaccine SC in the left arm. There were no concomitant medications. The pt had a negative vericella titer (0.19) on 04/23/2001. On 05/12/2001 the pt developed a chicken pox rash. He was seen in a health service center on 05/14/2001. The pt was afebrile and the rash was present on his "face, arms, trunk, legs, and back." The pt was placed on oral Valtrex, one gram every eight hours for three days. The pt's experiences resolved on 05/17/2001 when the "chicken pox rash" was noted as "crusted." It was reported the pt was to have repeat titers in mid June 2001. Additional info is not expected.